======= GTF3C1 ======= == Gene Information == * **Official Symbol**: GTF3C1 * **Official Name**: general transcription factor IIIC subunit 1 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=2975|2975]] * **UniProt**: [[https://www.uniprot.org/uniprot/Q12789|Q12789]] * **Interactions**: [[https://thebiogrid.org/search.php?search=GTF3C1&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20GTF3C1|Open PubMed]] * **OMIM**: [[https://omim.org/entry/603246|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Required for RNA polymerase III-mediated transcription. Component of TFIIIC that initiates transcription complex assembly on tRNA and is required for transcription of 5S rRNA and other stable nuclear and cytoplasmic RNAs. Binds to the box B promoter element. |B-block TFIIIC| |RNA polymerase III type 1 promoter sequence-specific DNA binding| |RNA polymerase III type 2 promoter sequence-specific DNA binding| |RNA polymerase III general transcription initiation factor activity| |transcription factor TFIIIC complex| |5S class rRNA transcription by RNA polymerase III| |tRNA transcription by RNA polymerase III| |tRNA transcription| |transcription initiation from RNA polymerase III promoter| |rRNA transcription| |transcription by RNA polymerase III| |ncRNA transcription| |ribonucleoprotein complex| |DNA-templated transcription, initiation| |transcription, DNA-templated| |nucleic acid-templated transcription| |RNA biosynthetic process| |nucleolus| |nucleobase-containing compound biosynthetic process| |heterocycle biosynthetic process| |aromatic compound biosynthetic process| |organic cyclic compound biosynthetic process| |DNA binding| |cellular nitrogen compound biosynthetic process| |RNA metabolic process| |cellular macromolecule biosynthetic process| |macromolecule biosynthetic process| |membrane| |gene expression| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp449|Arsenic trioxide 60μM R08 exp449]]|-2.55| |[[:results:exp291|LLY-284 2.6μM R06 exp291]]|-2.37| |[[:results:exp288|HMS-I2 10μM R06 exp288]]|-2.21| |[[:results:exp272|CHIR-124 0.04μM R06 exp272]]|-2.2| |[[:results:exp299|Talazoparib 0.006μM R06 exp299]]|-1.76| |[[:results:exp302|35°C R06 exp302]]|-1.75| |[[:results:exp29|Rapamycin 1μM R00 exp29]]|-1.7| |[[:results:exp4|Actinomycin-D 0.01μM R00 exp4]]|1.73| |[[:results:exp531|THZ1 0.06μM R08 exp531]]|1.75| ^Gene^Correlation^ |[[:human genes:y:yars|YARS]]|0.418| Global Fraction of Cell Lines Where Essential: 43/726 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|0/1| |909776.0|0/1| |bile duct|0/28| |blood|3/28| |bone|2/25| |breast|2/33| |central nervous system|3/56| |cervix|0/4| |colorectal|0/17| |esophagus|0/13| |fibroblast|0/1| |gastric|0/15| |kidney|1/21| |liver|5/20| |lung|6/75| |lymphocyte|2/14| |ovary|1/26| |pancreas|1/24| |peripheral nervous system|1/16| |plasma cell|1/15| |prostate|1/1| |skin|0/24| |soft tissue|0/7| |thyroid|0/2| |upper aerodigestive|1/22| |urinary tract|1/29| |uterus|0/5| == Essentiality in NALM6 == * **Essentiality Rank**: 350 * **Expression level (log2 read counts)**: 8.29 {{:chemogenomics:nalm6 dist.png?nolink |}}